Clinical Trial: Expression of AMP-activated Protein Kinase (AMPK) Protein in Lung Adenocarcinoma
Study Status: Active, not recruiting
Recruit Status: Unknown status
Study Type: Observational
Official Title: Expression of AMP-activated Protein Kinase (AMPK) Protein in Lung Adenocarcinoma
Brief Summary: AMP-activated protein kinase (AMPK) is an evolutionally conserved protein kinase that serves as an energy guardian to help cells adapt to various metabolic stress including hypoxia. Because the role of AMPK in cancers has not been fully elucidated, in this study we investigated the expression and activation of AMPK in lung adenocarcinoma (LADC) cells and tissue.
Detailed Summary:
Sponsor: China Medical University Hospital
Current Primary Outcome:
Original Primary Outcome:
Current Secondary Outcome:
Original Secondary Outcome:
Information By: China Medical University Hospital
Dates:
Date Received: November 24, 2010
Date Started: September 2010
Date Completion:
Last Updated: November 26, 2010
Last Verified: September 2010